九典制药：产品取得注册证，产品名称为“马来酸曲美布汀片”

Company Overview - JiuDian Pharmaceutical (SZ 300705) announced on December 11 that it has received a drug registration certificate from the National Medical Products Administration for its product "Malaise Acid Trimebutine Tablets" [1] - As of the announcement, JiuDian Pharmaceutical has a market capitalization of 7.8 billion yuan [1] Revenue Composition - For the first half of 2025, the revenue composition of JiuDian Pharmaceutical is as follows: - Pharmaceutical preparations account for 82.47% - Raw materials account for 7.65% - Pharmaceutical excipients account for 6.03% - Plant extracts and others account for 3.16% - Technology transfer and services account for 0.63% [1]